Mackwell Health has announced a partnership with GE Current, a Daintree company to collaborate in the field of LED UV disinfection technology. The partnership will extend Current’s 365DisInFx UV Technology to the European, Middle Eastern and Australia/New Zealand markets.
The 365DisInFx UV technology leverages LEDs to help reduce the potential spread of certain common infection-causing pathogens. This allows for continuous disinfection in spaces while occupants are present.
Mackwell Health is a new division of the Mackwell Group of companies, a market leader with a 42-year track record in the manufacture and supply of safety-critical lighting systems to global markets. 365DisInFx UV technology complements Mackwell Health’s existing portfolio of UV disinfection solutions, such as the ProtectivAIR UV respirator and Whitebox Smart UV-C disinfection chambers for the healthcare industry.
Mackwell Health is also a specialist in European regulatory standards for UV germicidal systems, and a key element of the partnership will use this expertise to ensure that 365DisInFx UV technology can be applied correctly in these new markets according to the correct local standards. Mackwell will also work with its customer base to identify further embodiments of the 365DisInFx UV technology that are suitable for the European, Middle Eastern and Australia/New Zealand markets, and develop and manufacture products accordingly.
Nick Brangwin, CEO of Mackwell Group, said: "We are delighted to announce this partnership with GE Current, a Daintree company. It was clear as soon as we began discussions that our two companies share a common philosophy, which is to exploit the vast potential of UV technology, but in a responsible way, backed by science and with a comprehensive body of evidence. Our partnership will allow many more people across the world to be kept much safer from infectious disease.”
The 365DisInFx UVC solutions can help reduce viruses in air. Current’s latest testing with SARS-CoV-2 resulted in 90% inactivation of the aerosolized virus within two hours. The test was conducted in an 36m3 room equipped with twelve 365DisInFx LPU prototype devices, configured for eight-hour Permissible Exposure Time (PET) at head height. SARS-CoV-2 Isolate USA-CA1/2020 was used in this testing, and results are expected to be representative of other SARS-CoV-2 isolates or strains.
Manish Bhandari, CEO of GE Current, a Daintree company, said: "We are excited to align with Mackwell Health to bring 365DisInFx technology to more customers across the globe. We continue to invest in technology and innovation and enable more partners to deliver products that are solving real world challenges.”
